ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TDOC vs OMDA // EV/EBITDA & P/E VALUATION

Teladoc Health Inc. (NYSE) VS. Omada Health Inc. (NASDAQ) • 15-METRIC TALLY: TDOC 3 — OMDA 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDOC VS. OMDA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TDOC OMDA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 65.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -17.00% -15.70% -1.30 OMDA /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield 18.00% 1.41% +16.59 TDOC /fcf-yield <GO>
Operating Margin -10.40% -4.60% -5.80 OMDA /operating-margins <GO>
Net Profit Margin -7.90% -4.90% -3.00 OMDA /net-margins <GO>
Revenue Growth (YoY) -1.50% 53.20% -54.70 OMDA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.45 8.93 -8.48 OMDA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 79.0 43.6 +35.44 TDOC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.08 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 32.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.59B $1.20B $383.2M TDOC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TDOC REV OMDA REV TDOC GROSS % OMDA GROSS % TDOC FCF OMDA FCF
FY 2025 $2.53B $260.2M — 65.7% $285.5M $16.9M
FY 2024 $2.57B $169.8M — 60.6% $282.9M -$34.8M
FY 2023 $2.60B $122.8M — — $232.9M -$49.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDOC // BETA 1.08
OMDA // BETA —